LivaNova (LIVN) Profit After Tax (2014 - 2026)
LivaNova (LIVN) reported Profit After Tax of $22.3 million for Q1 2026, up 106.81% on a YoY basis from $10.8 million in Q1 2025, and down 27.87% sequentially from $30.9 million in Q4 2025.
LivaNova (LIVN) Profit After Tax (2014 - 2026) Analysis & Trends
LivaNova (LIVN) has 13 years of Profit After Tax data on file, last reported at $22.3 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 106.81% year-over-year to $22.3 million; the trailing twelve-month figure through Mar 2026 stood at $107.1 million (up 148.23% YoY), and the FY2025 full-year result was -$242.5 million, down 483.45% from the prior year.
- Profit After Tax slipped to $22.3 million in Q1 2026, from $30.9 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $55.9 million in Q4 2024 to a low of -$327.3 million in Q1 2025.
- A 5-year average of -$13.3 million and a median of $16.3 million in 2024 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax surged 1314.11% in 2024 and tumbled 680.4% in 2025, its largest moves.
- Tracing LIVN's Profit After Tax over 5 years: stood at $1.7 million in 2022, then soared by 883.68% to $16.3 million in 2023, then soared by 242.07% to $55.9 million in 2024, then plunged by 44.7% to $30.9 million in 2025, then retreated by 27.87% to $22.3 million in 2026.
- Business Quant data shows LIVN's Profit After Tax at $22.3 million in Q1 2026, $30.9 million in Q4 2025, and $26.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.36 Bn | 175.06 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 108.02 Bn | 98.80 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.21 Bn | 66.76 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 24.11 Bn | 20.99 Bn | 2.07 Bn | 170.93 Mn |
| 10 | LivaNova | 4.40 Bn | 3.86 Bn | 243.75 Mn | 22.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.29 Mn |
| Dec 31, 2025 | 30.91 Mn |
| Sep 30, 2025 | 26.78 Mn |
| Jun 30, 2025 | 27.16 Mn |
| Mar 31, 2025 | -327.32 Mn |
| Dec 31, 2024 | 55.89 Mn |
| Sep 30, 2024 | 32.95 Mn |
| Jun 30, 2024 | 16.33 Mn |
| Mar 31, 2024 | -41.94 Mn |
| Dec 31, 2023 | 16.34 Mn |
| Sep 30, 2023 | -7.32 Mn |
| Jun 30, 2023 | 1.16 Mn |
| Mar 31, 2023 | 7.37 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Sep 30, 2022 | -107.34 Mn |
| Jun 30, 2022 | 16.44 Mn |
| Mar 31, 2022 | 2.99 Mn |
| Dec 31, 2021 | -5.13 Mn |
| Sep 30, 2021 | -43.44 Mn |
| Jun 30, 2021 | -56.49 Mn |